Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.
- Conditions
- Visual Acuity
- Interventions
- Device: EyeQue Insight
- Registration Number
- NCT04474041
- Lead Sponsor
- EyeQue Corp.
- Brief Summary
Open label exploratory study of the EyeQue Insight in healthy volunteers \>=7 years of age.
- Detailed Description
The primary objective of this study is to determine whether the EyeQue Insight (ETDRS visual acuity test) yields results similar to the standard ETDRS eyechart in the office.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 89
- Male or Female
- Ages =>7 y.o.
- Subjects that are minors (<18 years old) must have a parent or legal guardian.
- Binocular vision
- Willing and able to give informed consent and follow all study procedures and requirements
- Fluent in English
-
Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19.
-
Has traveled outside the country within the last 4 weeks
-
Medications:
a. Taking medications that may affect ability to follow instructions.
-
Eye Disease:
a. Subjects with eye disease deemed by the Investigator to be inappropriate for the study such as an active eye infection.
-
Subjects that:
- Lack physical dexterity to properly operate the EyeQue App on the smartphone
- Lack the ability to follow instruction
- Lack binocular vision
- Lack the ability to maintain both eyes open
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Visual Acuity with a Hand-held Device Supported by Mobile App. EyeQue Insight The Insight will be compared to a standard ETDRS eyechart
- Primary Outcome Measures
Name Time Method Acuity Visit 1 Visit 1: Day 0 Variance of best-corrected (BCVA) monocular VA of each participant's OD and OS measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1.
- Secondary Outcome Measures
Name Time Method Acuity Visit 1 and 2 Visit 1 (Day 0) and Visit 2 (Day 7) Variance of the best-corrected VA (BCVA) of each participant's OD, OS, and OU measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1 and Visit 2.
Trial Locations
- Locations (1)
EyeQue
🇺🇸Newark, California, United States